Dan Meyers, M.D.
Chief Medical Officer
Dan Meyers has led over 40 clinical studies ranging from first-in-human Phase 1 studies to pivotal Phase 3 and post-approval programs. As a Senior Translational Medicine Expert at Novartis, he chaired the scientific review committee for all general medicine studies within NIBR. More recently, Dan served as head of product development for the Janssen Human Microbiome Institute.
Dan received his M.D. from the University of Washington School of Medicine, where he also completed a fellowship in Metabolism, Endocrinology, and Nutrition.